HomeISCNF • OTCMKTS
add
Isracann Biosciences Ord Shs
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.43M | -49.49% |
Net income | -4.69M | 81.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.39M | 49.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.94K | -89.08% |
Total assets | 4.09M | -7.04% |
Total liabilities | 3.80M | 716.83% |
Total equity | 290.37K | — |
Shares outstanding | 175.99M | — |
Price to book | ∞ | — |
Return on assets | -35.83% | — |
Return on capital | -72.00% | — |
Cash Flow
Net change in cash
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Net income | -4.69M | 81.34% |
Cash from operations | -1.75M | 58.52% |
Cash from investing | -77.15K | -157.73% |
Cash from financing | 129.91K | -94.00% |
Net change in cash | -1.74M | 9.73% |
Free cash flow | -811.03K | 64.60% |
About
Founded
2010
Website
